Back

AMPK/PGC1 activation by melatonin attenuates acute doxorubicin cardiotoxicity

27 August 2018 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 4 - Arrhythmia and cardio protection pharmacotherapy Cardiovascular Pharmacotherapy, Other ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Dong Liu

Fuwai Hospital, CAMS and PUMC, Beijing (China)

5 More presentations in this session

Presentation thumbnail
Mr S. Kjeldsen (Gentofte, DK)
Abstract
Presentation thumbnail
Doctor J. Milner (Santa Maria da Feira, PT)
Abstract
Presentation thumbnail
Ms P. Madhavapeddi (Newark, US)
Abstract Slides
Presentation thumbnail
Miss C. Citerni (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Assistant Professor M. Kiyokuni (Yokohama, JP)
Abstract

Access the full session

Session thumbnail
Poster Session 4 - Arrhythmia and cardio protection pharmacotherapy

The Event

Event poster

ESC Congress 2018

27 August 2018 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Melatonin attenuates an impairment of metabolic reprogramming in doxorubicin-induced cardiotoxicity: insights from metabolomics study in rats
27 August 2023
thumbnail
Webinar
Integrating and organising cardiac imaging and biomarkers in cardio-oncology: which, when and how frequently
24 February 2021
thumbnail
Congress Presentation
Administration of doxorubicin increases the sensitivity of the mitochondrial permeability transition pore to calcium and causes pathological changes in the electrocardiography.
21 May 2023
thumbnail
Congress Presentation
Dapagliflozin in primary prevention of cardiotoxicity induced by anthracycline-trastuzumab therapy through activation of pAMPK and inhibition of MyD88 and NLRP-3
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources